Affiliation:
1. Children's Hospital, University of Munich, Germany.
Abstract
We evaluated the pharmacokinetics of rectally administered zidovudine (ZDV) in 10 human immunodeficiency virus-infected adults. After rectal administration of an aqueous ZDV solution (250 mg of ZDV), mean peak ZDV levels were 1.3 +/- 0.7 micromol/liter (mean +/- standard deviation) versus 5.0 +/- 2.2 micromol/liter (P < 0.0001) after oral intake of a 250-mg ZDV capsule. The half-life at beta phase was 87.8 +/- 39.6 min for rectally administered ZDV versus 55.8 +/- 20.1 min (P = 0.035) for orally administered ZDV. The mean area under the concentration-time curve from 0 min to infinity was 232 +/- 181 micromol/liter x min after rectal administration versus 362 +/- 110 micromol/liter x min after oral intake. Although the two routes were not bioequivalent, ZDV was absorbed considerably after rectal administration, with a pharmacokinetic profile resembling that of a sustained-release device.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference21 articles.
1. Pharmacokinetics of zidovudine administered by continuous infusion in children;Balis F. M.;Ann. Intern. Med.,1989
2. Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy;Bilello J. A.;Antimicrob. Agents Chemother.,1994
3. Pharmacokinetics and bioavailability of zidovudine in humans;Blum M. R.;Am. J. Med.,1988
4. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults;Centers for Disease Control.;Morbid. Mortal. Weekly Rep.,1992
5. Chow S.-C. and J.-P. Liu. 1992. Design and analysis of bioavailability and bioequivalence studies. Marcel Dekker Inc. New York N.Y.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献